The global Recombinant Protein Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant Protein Drugs in various end use industries. The expanding demands from the Pharmaceutical Industry and Others, are propelling Recombinant Protein Drugs market. rhIFN, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the rhEPO segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant Protein Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Recombinant Protein Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Recombinant Protein Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant Protein Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Recombinant Protein Drugs covered in this report include Novo Nordisk, Amgen, Sanofi, Eli Lilly, Merck Serono, Ortho Biotech, Roche, Kyowa Hakko Kirin and Pharmingen, etc.

The global Recombinant Protein Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Novo Nordisk

Amgen

Sanofi

Eli Lilly

Merck Serono

Ortho Biotech

Roche

Kyowa Hakko Kirin

Pharmingen

Abcam

GenSci

SL PHARM

Dongbao Pharm

Ankebio

NCPC

Heng Rui

Scope of Recombinant Protein Drugs - Market Report

Report Metric	Details
Report Name	Recombinant Protein Drugs - Market
CAGR	5%
Global Recombinant Protein Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Protein Drugs market, Segment by Type:	rhIFN rhEPO rhG-CSF Recombinant insulin Others
Global Recombinant Protein Drugs market, by Application	Pharmaceutical Industry Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Recombinant Protein Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Recombinant Protein Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Recombinant Protein Drugs - Market report?

Ans: The Applications covered in the Recombinant Protein Drugs - Market report are Pharmaceutical Industry, Others

What are the Type segmentation covered in the Recombinant Protein Drugs - Market report?

Ans: The Types covered in the Recombinant Protein Drugs - Market report are rhIFN, rhEPO, rhG-CSF, Recombinant insulin, Others

1 Recombinant Protein Drugs Market Overview

1.1 Recombinant Protein Drugs Product Overview

1.2 Recombinant Protein Drugs Market Segment by Type

1.2.1 rhIFN

1.2.2 rhEPO

1.2.3 rhG-CSF

1.2.4 Recombinant insulin

1.2.5 Others

1.3 Global Recombinant Protein Drugs Market Size by Type

1.3.1 Global Recombinant Protein Drugs Market Size Overview by Type (2018-2029)

1.3.2 Global Recombinant Protein Drugs Historic Market Size Review by Type (2018-2023)

1.3.3 Global Recombinant Protein Drugs Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Recombinant Protein Drugs Sales Breakdown by Type (2018-2023)

1.4.2 Europe Recombinant Protein Drugs Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Recombinant Protein Drugs Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Recombinant Protein Drugs Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Recombinant Protein Drugs Sales Breakdown by Type (2018-2023)

2 Global Recombinant Protein Drugs Market Competition by Company

2.1 Global Top Players by Recombinant Protein Drugs Sales (2018-2023)

2.2 Global Top Players by Recombinant Protein Drugs Revenue (2018-2023)

2.3 Global Top Players by Recombinant Protein Drugs Price (2018-2023)

2.4 Global Top Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Recombinant Protein Drugs Market Competitive Situation and Trends

2.5.1 Recombinant Protein Drugs Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Protein Drugs Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Protein Drugs as of 2022)

2.7 Date of Key Manufacturers Enter into Recombinant Protein Drugs Market

2.8 Key Manufacturers Recombinant Protein Drugs Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Recombinant Protein Drugs Status and Outlook by Region

3.1 Global Recombinant Protein Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Recombinant Protein Drugs Historic Market Size by Region

3.2.1 Global Recombinant Protein Drugs Sales in Volume by Region (2018-2023)

3.2.2 Global Recombinant Protein Drugs Sales in Value by Region (2018-2023)

3.2.3 Global Recombinant Protein Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Recombinant Protein Drugs Forecasted Market Size by Region

3.3.1 Global Recombinant Protein Drugs Sales in Volume by Region (2024-2029)

3.3.2 Global Recombinant Protein Drugs Sales in Value by Region (2024-2029)

3.3.3 Global Recombinant Protein Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Recombinant Protein Drugs by Application

4.1 Recombinant Protein Drugs Market Segment by Application

4.1.1 Pharmaceutical Industry

4.1.2 Others

4.2 Global Recombinant Protein Drugs Market Size by Application

4.2.1 Global Recombinant Protein Drugs Market Size Overview by Application (2018-2029)

4.2.2 Global Recombinant Protein Drugs Historic Market Size Review by Application (2018-2023)

4.2.3 Global Recombinant Protein Drugs Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Recombinant Protein Drugs Sales Breakdown by Application (2018-2023)

4.3.2 Europe Recombinant Protein Drugs Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Recombinant Protein Drugs Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Recombinant Protein Drugs Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Recombinant Protein Drugs Sales Breakdown by Application (2018-2023)

5 North America Recombinant Protein Drugs by Country

5.1 North America Recombinant Protein Drugs Historic Market Size by Country

5.1.1 North America Recombinant Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Recombinant Protein Drugs Sales in Volume by Country (2018-2023)

5.1.3 North America Recombinant Protein Drugs Sales in Value by Country (2018-2023)

5.2 North America Recombinant Protein Drugs Forecasted Market Size by Country

5.2.1 North America Recombinant Protein Drugs Sales in Volume by Country (2024-2029)

5.2.2 North America Recombinant Protein Drugs Sales in Value by Country (2024-2029)

6 Europe Recombinant Protein Drugs by Country

6.1 Europe Recombinant Protein Drugs Historic Market Size by Country

6.1.1 Europe Recombinant Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Recombinant Protein Drugs Sales in Volume by Country (2018-2023)

6.1.3 Europe Recombinant Protein Drugs Sales in Value by Country (2018-2023)

6.2 Europe Recombinant Protein Drugs Forecasted Market Size by Country

6.2.1 Europe Recombinant Protein Drugs Sales in Volume by Country (2024-2029)

6.2.2 Europe Recombinant Protein Drugs Sales in Value by Country (2024-2029)

7 Asia-Pacific Recombinant Protein Drugs by Region

7.1 Asia-Pacific Recombinant Protein Drugs Historic Market Size by Region

7.1.1 Asia-Pacific Recombinant Protein Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Recombinant Protein Drugs Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Recombinant Protein Drugs Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Recombinant Protein Drugs Forecasted Market Size by Region

7.2.1 Asia-Pacific Recombinant Protein Drugs Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Recombinant Protein Drugs Sales in Value by Region (2024-2029)

8 Latin America Recombinant Protein Drugs by Country

8.1 Latin America Recombinant Protein Drugs Historic Market Size by Country

8.1.1 Latin America Recombinant Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Recombinant Protein Drugs Sales in Volume by Country (2018-2023)

8.1.3 Latin America Recombinant Protein Drugs Sales in Value by Country (2018-2023)

8.2 Latin America Recombinant Protein Drugs Forecasted Market Size by Country

8.2.1 Latin America Recombinant Protein Drugs Sales in Volume by Country (2024-2029)

8.2.2 Latin America Recombinant Protein Drugs Sales in Value by Country (2024-2029)

9 Middle East and Africa Recombinant Protein Drugs by Country

9.1 Middle East and Africa Recombinant Protein Drugs Historic Market Size by Country

9.1.1 Middle East and Africa Recombinant Protein Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Recombinant Protein Drugs Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Recombinant Protein Drugs Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Recombinant Protein Drugs Forecasted Market Size by Country

9.2.1 Middle East and Africa Recombinant Protein Drugs Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Recombinant Protein Drugs Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Novo Nordisk

10.1.1 Novo Nordisk Company Information

10.1.2 Novo Nordisk Introduction and Business Overview

10.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Novo Nordisk Recombinant Protein Drugs Products Offered

10.1.5 Novo Nordisk Recent Development

10.2 Amgen

10.2.1 Amgen Company Information

10.2.2 Amgen Introduction and Business Overview

10.2.3 Amgen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Amgen Recombinant Protein Drugs Products Offered

10.2.5 Amgen Recent Development

10.3 Sanofi

10.3.1 Sanofi Company Information

10.3.2 Sanofi Introduction and Business Overview

10.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Sanofi Recombinant Protein Drugs Products Offered

10.3.5 Sanofi Recent Development

10.4 Eli Lilly

10.4.1 Eli Lilly Company Information

10.4.2 Eli Lilly Introduction and Business Overview

10.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Eli Lilly Recombinant Protein Drugs Products Offered

10.4.5 Eli Lilly Recent Development

10.5 Merck Serono

10.5.1 Merck Serono Company Information

10.5.2 Merck Serono Introduction and Business Overview

10.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Merck Serono Recombinant Protein Drugs Products Offered

10.5.5 Merck Serono Recent Development

10.6 Ortho Biotech

10.6.1 Ortho Biotech Company Information

10.6.2 Ortho Biotech Introduction and Business Overview

10.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Ortho Biotech Recombinant Protein Drugs Products Offered

10.6.5 Ortho Biotech Recent Development

10.7 Roche

10.7.1 Roche Company Information

10.7.2 Roche Introduction and Business Overview

10.7.3 Roche Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Roche Recombinant Protein Drugs Products Offered

10.7.5 Roche Recent Development

10.8 Kyowa Hakko Kirin

10.8.1 Kyowa Hakko Kirin Company Information

10.8.2 Kyowa Hakko Kirin Introduction and Business Overview

10.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Products Offered

10.8.5 Kyowa Hakko Kirin Recent Development

10.9 Pharmingen

10.9.1 Pharmingen Company Information

10.9.2 Pharmingen Introduction and Business Overview

10.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Pharmingen Recombinant Protein Drugs Products Offered

10.9.5 Pharmingen Recent Development

10.10 Abcam

10.10.1 Abcam Company Information

10.10.2 Abcam Introduction and Business Overview

10.10.3 Abcam Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Abcam Recombinant Protein Drugs Products Offered

10.10.5 Abcam Recent Development

10.11 GenSci

10.11.1 GenSci Company Information

10.11.2 GenSci Introduction and Business Overview

10.11.3 GenSci Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.11.4 GenSci Recombinant Protein Drugs Products Offered

10.11.5 GenSci Recent Development

10.12 SL PHARM

10.12.1 SL PHARM Company Information

10.12.2 SL PHARM Introduction and Business Overview

10.12.3 SL PHARM Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.12.4 SL PHARM Recombinant Protein Drugs Products Offered

10.12.5 SL PHARM Recent Development

10.13 Dongbao Pharm

10.13.1 Dongbao Pharm Company Information

10.13.2 Dongbao Pharm Introduction and Business Overview

10.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.13.4 Dongbao Pharm Recombinant Protein Drugs Products Offered

10.13.5 Dongbao Pharm Recent Development

10.14 Ankebio

10.14.1 Ankebio Company Information

10.14.2 Ankebio Introduction and Business Overview

10.14.3 Ankebio Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.14.4 Ankebio Recombinant Protein Drugs Products Offered

10.14.5 Ankebio Recent Development

10.15 NCPC

10.15.1 NCPC Company Information

10.15.2 NCPC Introduction and Business Overview

10.15.3 NCPC Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.15.4 NCPC Recombinant Protein Drugs Products Offered

10.15.5 NCPC Recent Development

10.16 Heng Rui

10.16.1 Heng Rui Company Information

10.16.2 Heng Rui Introduction and Business Overview

10.16.3 Heng Rui Recombinant Protein Drugs Sales, Revenue and Gross Margin (2018-2023)

10.16.4 Heng Rui Recombinant Protein Drugs Products Offered

10.16.5 Heng Rui Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Recombinant Protein Drugs Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Recombinant Protein Drugs Industrial Chain Analysis

11.4 Recombinant Protein Drugs Market Dynamics

11.4.1 Recombinant Protein Drugs Industry Trends

11.4.2 Recombinant Protein Drugs Market Drivers

11.4.3 Recombinant Protein Drugs Market Challenges

11.4.4 Recombinant Protein Drugs Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Recombinant Protein Drugs Distributors

12.3 Recombinant Protein Drugs Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Major Company of rhIFN

Table 2. Major Company of rhEPO

Table 3. Major Company of rhG-CSF

Table 4. Major Company of Recombinant insulin

Table 5. Major Company of Others

Table 6. Global Recombinant Protein Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Recombinant Protein Drugs Sales by Type (2018-2023) & (K Doses)

Table 8. Global Recombinant Protein Drugs Sales Market Share in Volume by Type (2018-2023)

Table 9. Global Recombinant Protein Drugs Sales by Type (2018-2023) & (US& Million)

Table 10. Global Recombinant Protein Drugs Market Share in Value by Type (2018-2023)

Table 11. Global Recombinant Protein Drugs Price by Type (2018-2023) & (USD/Dose)

Table 12. Global Recombinant Protein Drugs Sales by Type (2024-2029) & (K Doses)

Table 13. Global Recombinant Protein Drugs Sales Market Share in Volume by Type (2024-2029)

Table 14. Global Recombinant Protein Drugs Sales by Type (2024-2029) & (US$ Million)

Table 15. Global Recombinant Protein Drugs Sales Market Share in Value by Type (2024-2029)

Table 16. Global Recombinant Protein Drugs Price by Type (2024-2029) & (USD/Dose)

Table 17. North America Recombinant Protein Drugs Sales by Type (2018-2023) & (K Doses)

Table 18. North America Recombinant Protein Drugs Sales by Type (2018-2023) & (US$ Million)

Table 19. Europe Recombinant Protein Drugs Sales (K Doses) by Type (2018-2023)

Table 20. Europe Recombinant Protein Drugs Sales by Type (2018-2023) & (US$ Million)

Table 21. Asia-Pacific Recombinant Protein Drugs Sales (K Doses) by Type (2018-2023)

Table 22. Asia-Pacific Recombinant Protein Drugs Sales by Type (2018-2023) & (US$ Million)

Table 23. Latin America Recombinant Protein Drugs Sales (K Doses) by Type (2018-2023)

Table 24. Latin America Recombinant Protein Drugs Sales by Type (2018-2023) & (US$ Million)

Table 25. Middle East and Africa Recombinant Protein Drugs Sales (K Doses) by Type (2018-2023)

Table 26. Middle East and Africa Recombinant Protein Drugs Sales by Type (2018-2023) & (US$ Million)

Table 27. Global Recombinant Protein Drugs Sales by Company (2018-2023) & (K Doses)

Table 28. Global Recombinant Protein Drugs Sales Share by Company (2018-2023)

Table 29. Global Recombinant Protein Drugs Revenue by Company (2018-2023) & (US$ Million)

Table 30. Global Recombinant Protein Drugs Revenue Share by Company (2018-2023)

Table 31. Global Market Recombinant Protein Drugs Price by Company (2018-2023) & (USD/Dose)

Table 32. Global Recombinant Protein Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 33. Global Recombinant Protein Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Protein Drugs as of 2022)

Table 35. Date of Key Manufacturers Enter into Recombinant Protein Drugs Market

Table 36. Key Manufacturers Recombinant Protein Drugs Product Type

Table 37. Mergers & Acquisitions, Expansion Plans

Table 38. Global Recombinant Protein Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 39. Global Recombinant Protein Drugs Sales by Region (2018-2023) & (K Doses)

Table 40. Global Recombinant Protein Drugs Sales Market Share in Volume by Region (2018-2023)

Table 41. Global Recombinant Protein Drugs Sales by Region (2018-2023) & (US$ Million)

Table 42. Global Recombinant Protein Drugs Sales Market Share in Value by Region (2018-2023)

Table 43. Global Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 44. Global Recombinant Protein Drugs Sales by Region (2024-2029) & (K Doses)

Table 45. Global Recombinant Protein Drugs Sales Market Share in Volume by Region (2024-2029)

Table 46. Global Recombinant Protein Drugs Sales by Region (2024-2029) & (US$ Million)

Table 47. Global Recombinant Protein Drugs Sales Market Share in Value by Region (2024-2029)

Table 48. Global Recombinant Protein Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)

Table 49. Global Recombinant Protein Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 50. Global Recombinant Protein Drugs Sales by Application (2018-2023) & (K Doses)

Table 51. Global Recombinant Protein Drugs Sales Market Share in Volume by Application (2018-2023)

Table 52. Global Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 53. Global Recombinant Protein Drugs Sales Market Share in Value by Application (2018-2023)

Table 54. Global Recombinant Protein Drugs Price by Application (2018-2023) & (USD/Dose)

Table 55. Global Recombinant Protein Drugs Sales by Application (2024-2029) & (K Doses)

Table 56. Global Recombinant Protein Drugs Sales Market Share in Volume by Application (2024-2029)

Table 57. Global Recombinant Protein Drugs Sales by Application (2024-2029) & (US$ Million)

Table 58. Global Recombinant Protein Drugs Sales Market Share in Value by Application (2024-2029)

Table 59. Global Recombinant Protein Drugs Price by Application (2024-2029) & (USD/Dose)

Table 60. North America Recombinant Protein Drugs Sales by Application (2018-2023) (K Doses)

Table 61. North America Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 62. Europe Recombinant Protein Drugs Sales by Application (2018-2023) (K Doses)

Table 63. Europe Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 64. Asia-Pacific Recombinant Protein Drugs Sales by Application (2018-2023) (K Doses)

Table 65. Asia-Pacific Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 66. Latin America Recombinant Protein Drugs Sales by Application (2018-2023) (K Doses)

Table 67. Latin America Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 68. Middle East and Africa Recombinant Protein Drugs Sales by Application (2018-2023) (K Doses)

Table 69. Middle East and Africa Recombinant Protein Drugs Sales by Application (2018-2023) & (US$ Million)

Table 70. North America Recombinant Protein Drugs Sales by Country (2018-2023) & (K Doses)

Table 71. North America Recombinant Protein Drugs Sales Market Share in Volume by Country (2018-2023)

Table 72. North America Recombinant Protein Drugs Sales by Country (2018-2023) & (US$ Million)

Table 73. North America Recombinant Protein Drugs Sales Market Share in Value by Country (2018-2023)

Table 74. North America Recombinant Protein Drugs Sales by Country (2024-2029) & (K Doses)

Table 75. North America Recombinant Protein Drugs Sales Market Share in Volume by Country (2024-2029)

Table 76. North America Recombinant Protein Drugs Sales by Country (2024-2029) & (US$ Million)

Table 77. North America Recombinant Protein Drugs Sales Market Share in Value by Country (2024-2029)

Table 78. Europe Recombinant Protein Drugs Sales by Country (2018-2023) & (K Doses)

Table 79. Europe Recombinant Protein Drugs Sales Market Share in Volume by Country (2018-2023)

Table 80. Europe Recombinant Protein Drugs Sales by Country (2018-2023) & (US$ Million)

Table 81. Europe Recombinant Protein Drugs Sales Market Share in Value by Country (2018-2023)

Table 82. Europe Recombinant Protein Drugs Sales by Country (2024-2029) & (K Doses)

Table 83. Europe Recombinant Protein Drugs Sales Market Share in Volume by Country (2024-2029)

Table 84. Europe Recombinant Protein Drugs Sales by Country (2024-2029) & (US$ Million)

Table 85. Europe Recombinant Protein Drugs Sales Market Share in Value by Country (2024-2029)

Table 86. Asia-Pacific Recombinant Protein Drugs Sales by Region (2018-2023) & (K Doses)

Table 87. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Volume by Region (2018-2023)

Table 88. Asia-Pacific Recombinant Protein Drugs Sales by Region (2018-2023) & (US$ Million)

Table 89. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Value by Region (2018-2023)

Table 90. Asia-Pacific Recombinant Protein Drugs Sales by Region (2024-2029) & (K Doses)

Table 91. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Volume by Region (2024-2029)

Table 92. Asia-Pacific Recombinant Protein Drugs Sales by Region (2024-2029) & (US$ Million)

Table 93. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Value by Region (2024-2029)

Table 94. Latin America Recombinant Protein Drugs Sales by Country (2018-2023) & (K Doses)

Table 95. Latin America Recombinant Protein Drugs Sales Market Share in Volume by Country (2018-2023)

Table 96. Latin America Recombinant Protein Drugs Sales by Country (2018-2023) & (US$ Million)

Table 97. Latin America Recombinant Protein Drugs Sales Market Share in Value by Country (2018-2023)

Table 98. Latin America Recombinant Protein Drugs Sales by Country (2024-2029) & (K Doses)

Table 99. Latin America Recombinant Protein Drugs Sales Market Share in Volume by Country (2024-2029)

Table 100. Latin America Recombinant Protein Drugs Sales by Country (2024-2029) & (US$ Million)

Table 101. Latin America Recombinant Protein Drugs Sales Market Share in Value by Country (2024-2029)

Table 102. Middle East and Africa Recombinant Protein Drugs Sales by Country (2018-2023) & (K Doses)

Table 103. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Volume by Country (2018-2023)

Table 104. Middle East and Africa Recombinant Protein Drugs Sales by Country (2018-2023) & (US$ Million)

Table 105. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Value by Country (2018-2023)

Table 106. Middle East and Africa Recombinant Protein Drugs Sales by Country (2024-2029) & (K Doses)

Table 107. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Volume by Country (2024-2029)

Table 108. Middle East and Africa Recombinant Protein Drugs Sales by Country (2024-2029) & (US$ Million)

Table 109. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Value by Country (2024-2029)

Table 110. Novo Nordisk Company Information

Table 111. Novo Nordisk Introduction and Business Overview

Table 112. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 113. Novo Nordisk Recombinant Protein Drugs Product

Table 114. Novo Nordisk Recent Development

Table 115. Amgen Company Information

Table 116. Amgen Introduction and Business Overview

Table 117. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 118. Amgen Recombinant Protein Drugs Product

Table 119. Amgen Recent Development

Table 120. Sanofi Company Information

Table 121. Sanofi Introduction and Business Overview

Table 122. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 123. Sanofi Recombinant Protein Drugs Product

Table 124. Sanofi Recent Development

Table 125. Eli Lilly Company Information

Table 126. Eli Lilly Introduction and Business Overview

Table 127. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 128. Eli Lilly Recombinant Protein Drugs Product

Table 129. Eli Lilly Recent Development

Table 130. Merck Serono Company Information

Table 131. Merck Serono Introduction and Business Overview

Table 132. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 133. Merck Serono Recombinant Protein Drugs Product

Table 134. Merck Serono Recent Development

Table 135. Ortho Biotech Company Information

Table 136. Ortho Biotech Introduction and Business Overview

Table 137. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 138. Ortho Biotech Recombinant Protein Drugs Product

Table 139. Ortho Biotech Recent Development

Table 140. Roche Company Information

Table 141. Roche Introduction and Business Overview

Table 142. Roche Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 143. Roche Recombinant Protein Drugs Product

Table 144. Roche Recent Development

Table 145. Kyowa Hakko Kirin Company Information

Table 146. Kyowa Hakko Kirin Introduction and Business Overview

Table 147. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 148. Kyowa Hakko Kirin Recombinant Protein Drugs Product

Table 149. Kyowa Hakko Kirin Recent Development

Table 150. Pharmingen Company Information

Table 151. Pharmingen Introduction and Business Overview

Table 152. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 153. Pharmingen Recombinant Protein Drugs Product

Table 154. Pharmingen Recent Development

Table 155. Abcam Company Information

Table 156. Abcam Introduction and Business Overview

Table 157. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 158. Abcam Recombinant Protein Drugs Product

Table 159. Abcam Recent Development

Table 160. GenSci Company Information

Table 161. GenSci Introduction and Business Overview

Table 162. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 163. GenSci Recombinant Protein Drugs Product

Table 164. GenSci Recent Development

Table 165. SL PHARM Company Information

Table 166. SL PHARM Introduction and Business Overview

Table 167. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 168. SL PHARM Recombinant Protein Drugs Product

Table 169. SL PHARM Recent Development

Table 170. Dongbao Pharm Company Information

Table 171. Dongbao Pharm Introduction and Business Overview

Table 172. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 173. Dongbao Pharm Recombinant Protein Drugs Product

Table 174. Dongbao Pharm Recent Development

Table 175. Ankebio Company Information

Table 176. Ankebio Introduction and Business Overview

Table 177. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 178. Ankebio Recombinant Protein Drugs Product

Table 179. Ankebio Recent Development

Table 180. NCPC Company Information

Table 181. NCPC Introduction and Business Overview

Table 182. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 183. NCPC Recombinant Protein Drugs Product

Table 184. NCPC Recent Development

Table 185. Heng Rui Company Information

Table 186. Heng Rui Introduction and Business Overview

Table 187. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 188. Heng Rui Recombinant Protein Drugs Product

Table 189. Heng Rui Recent Development

Table 190. Key Raw Materials Lists

Table 191. Raw Materials Key Suppliers Lists

Table 192. Recombinant Protein Drugs Market Trends

Table 193. Recombinant Protein Drugs Market Drivers

Table 194. Recombinant Protein Drugs Market Challenges

Table 195. Recombinant Protein Drugs Market Restraints

Table 196. Recombinant Protein Drugs Distributors List

Table 197. Recombinant Protein Drugs Downstream Customers

Table 198. Research Programs/Design for This Report

Table 199. Key Data Information from Secondary Sources

Table 200. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Protein Drugs Product Picture

Figure 2. Global Recombinant Protein Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Recombinant Protein Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Recombinant Protein Drugs Sales Status and Outlook (2018-2029) & (K Doses)

Figure 5. Product Picture of rhIFN

Figure 6. Global rhIFN Sales YoY Growth (2018-2029) & (K Doses)

Figure 7. Product Picture of rhEPO

Figure 8. Global rhEPO Sales YoY Growth (2018-2029) & (K Doses)

Figure 9. Product Picture of rhG-CSF

Figure 10. Global rhG-CSF Sales YoY Growth (2018-2029) & (K Doses)

Figure 11. Product Picture of Recombinant insulin

Figure 12. Global Recombinant insulin Sales YoY Growth (2018-2029) & (K Doses)

Figure 13. Product Picture of Others

Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Doses)

Figure 15. Global Recombinant Protein Drugs Sales by Type (2018-2029) & (US$ Million)

Figure 16. Global Recombinant Protein Drugs Sales Market Share by Type in 2022 & 2029

Figure 17. North America Recombinant Protein Drugs Sales Market Share in Volume by Type in 2022

Figure 18. North America Recombinant Protein Drugs Sales Market Share in Value by Type in 2022

Figure 19. Europe Recombinant Protein Drugs Sales Market Share in Volume by Type in 2022

Figure 20. Europe Recombinant Protein Drugs Sales Market Share in Value by Type in 2022

Figure 21. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Volume by Type in 2022

Figure 22. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Value by Type in 2022

Figure 23. Latin America Recombinant Protein Drugs Sales Market Share in Volume by Type in 2022

Figure 24. Latin America Recombinant Protein Drugs Sales Market Share in Value by Type in 2022

Figure 25. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Volume by Type in 2022

Figure 26. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Value by Type in 2022

Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Protein Drugs Sales in 2022

Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Protein Drugs Revenue in 2022

Figure 29. Recombinant Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 30. Product Picture of Pharmaceutical Industry

Figure 31. Global Pharmaceutical Industry Sales YoY Growth (2018-2029) & (K Doses)

Figure 32. Product Picture of Others

Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Doses)

Figure 34. Global Recombinant Protein Drugs Sales by Application (2018-2029) & (US$ Million)

Figure 35. Global Recombinant Protein Drugs Sales Market Share by Application in 2022 & 2029

Figure 36. North America Recombinant Protein Drugs Sales Market Share in Volume by Application in 2022

Figure 37. North America Recombinant Protein Drugs Sales Market Share in Value by Application in 2022

Figure 38. Europe Recombinant Protein Drugs Sales Market Share in Volume by Application in 2022

Figure 39. Europe Recombinant Protein Drugs Sales Market Share in Value by Application in 2022

Figure 40. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Volume by Application in 2022

Figure 41. Asia-Pacific Recombinant Protein Drugs Sales Market Share in Value by Application in 2022

Figure 42. Latin America Recombinant Protein Drugs Sales Market Share in Volume by Application in 2022

Figure 43. Latin America Recombinant Protein Drugs Sales Market Share in Value by Application in 2022

Figure 44. Middle East and Africa Recombinant Protein Drugs Sales Market Share in Value by Application in 2022

Figure 45. Key Raw Materials Price

Figure 46. Recombinant Protein Drugs Manufacturing Cost Structure

Figure 47. Recombinant Protein Drugs Industrial Chain Analysis

Figure 48. Channels of Distribution

Figure 49. Distributors Profiles

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions